These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35677070)

  • 1. A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19.
    Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
    Res Sq; 2022 Jun; ():. PubMed ID: 35677070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
    Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Wang P; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
    Nat Biotechnol; 2023 Jan; 41(1):128-139. PubMed ID: 36217030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
    Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
    Khodadoost M; Niknam Z; Farahani M; Razzaghi M; Norouzinia M
    Gastroenterol Hepatol Bed Bench; 2020; 13(4):374-387. PubMed ID: 33244381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
    Khan MA; Islam ABMMK
    Front Mol Biosci; 2020; 7():598583. PubMed ID: 33585554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
    Hoffmann HH; Schneider WM; Sánchez-Rivera FJ; Luna JM; Ashbrook AW; Soto-Feliciano YM; Leal AA; Le Pen J; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
    bioRxiv; 2020 Sep; ():. PubMed ID: 32935098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2
    Fang J; Wu Q; Ye F; Cai C; Xu L; Gu Y; Wang Q; Liu AL; Tan W; Du GH
    Front Genet; 2021; 12():728960. PubMed ID: 34539756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
    Eskandarzade N; Ghorbani A; Samarfard S; Diaz J; Guzzi PH; Fariborzi N; Tahmasebi A; Izadpanah K
    Comput Biol Med; 2022 Jul; 146():105575. PubMed ID: 35533462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-resolution proximity labeling reveals anti-viral protein network and its structural changes against SARS-CoV-2 viral proteins.
    Lee YB; Jung M; Kim J; Charles A; Christ W; Kang J; Kang MG; Kwak C; Klingström J; Smed-Sörensen A; Kim JS; Mun JY; Rhee HW
    Cell Rep; 2023 Aug; 42(8):112835. PubMed ID: 37478010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV-2 studies.
    Koliński M; Kałużna E; Piwecka M
    Wiley Interdiscip Rev RNA; 2022 Nov; 13(6):e1727. PubMed ID: 35343064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
    Manivannan J; Sundaresan L
    Gene Rep; 2021 Dec; 25():101312. PubMed ID: 34401607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.
    Zheng X; Sun Z; Yu L; Shi D; Zhu M; Yao H; Li L
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome.
    Karunakaran KB; Balakrishnan N; Ganapathiraju M
    Res Sq; 2020 May; ():. PubMed ID: 32702734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.